Literature DB >> 16931840

Obsessive-compulsive disorder.

I Heyman1, D Mataix-Cols, N A Fineberg.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16931840      PMCID: PMC1553525          DOI: 10.1136/bmj.333.7565.424

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  21 in total

1.  The pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection (PANDAS) subgroup: separating fact from fiction.

Authors:  Susan E Swedo; Henrietta L Leonard; Judith L Rapoport
Journal:  Pediatrics       Date:  2004-04       Impact factor: 7.124

Review 2.  Understanding and treating obsessive-compulsive disorder.

Authors:  P M Salkovskis
Journal:  Behav Res Ther       Date:  1999-07

3.  Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obsessive-compulsive disorder: the Pediatric OCD Treatment Study (POTS) randomized controlled trial.

Authors: 
Journal:  JAMA       Date:  2004-10-27       Impact factor: 56.272

4.  Prevalence of obsessive-compulsive disorder in the British nationwide survey of child mental health.

Authors:  I Heyman; E Fombonne; H Simmons; T Ford; H Meltzer; R Goodman
Journal:  Br J Psychiatry       Date:  2001-10       Impact factor: 9.319

5.  Which SSRI? A meta-analysis of pharmacotherapy trials in pediatric obsessive-compulsive disorder.

Authors:  Daniel A Geller; Joseph Biederman; S Evelyn Stewart; Benjamin Mullin; Andrés Martin; Thomas Spencer; Stephen V Faraone
Journal:  Am J Psychiatry       Date:  2003-11       Impact factor: 18.112

Review 6.  Obsessive-compulsive disorder.

Authors:  Dan J Stein
Journal:  Lancet       Date:  2002-08-03       Impact factor: 79.321

7.  Distinct neural correlates of washing, checking, and hoarding symptom dimensions in obsessive-compulsive disorder.

Authors:  David Mataix-Cols; Sarah Wooderson; Natalia Lawrence; Michael J Brammer; Anne Speckens; Mary L Phillips
Journal:  Arch Gen Psychiatry       Date:  2004-06

8.  The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability.

Authors:  W K Goodman; L H Price; S A Rasmussen; C Mazure; R L Fleischmann; C L Hill; G R Heninger; D S Charney
Journal:  Arch Gen Psychiatry       Date:  1989-11

9.  Cognitive-behavioral family treatment of childhood obsessive-compulsive disorder: a controlled trial.

Authors:  Paula Barrett; Lara Healy-Farrell; John S March
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2004-01       Impact factor: 8.829

10.  Cerebral glucose metabolism in obsessive-compulsive hoarding.

Authors:  Sanjaya Saxena; Arthur L Brody; Karron M Maidment; Erlyn C Smith; Narineh Zohrabi; Elyse Katz; Stephanie K Baker; Lewis R Baxter
Journal:  Am J Psychiatry       Date:  2004-06       Impact factor: 18.112

View more
  31 in total

Review 1.  Serotonin 5-HT7 receptor agents: Structure-activity relationships and potential therapeutic applications in central nervous system disorders.

Authors:  Marcello Leopoldo; Enza Lacivita; Francesco Berardi; Roberto Perrone; Peter B Hedlund
Journal:  Pharmacol Ther       Date:  2010-10-20       Impact factor: 12.310

Review 2.  Role of the 5-HT7 receptor in the central nervous system: from current status to future perspectives.

Authors:  Anne Matthys; Guy Haegeman; Kathleen Van Craenenbroeck; Peter Vanhoenacker
Journal:  Mol Neurobiol       Date:  2011-03-22       Impact factor: 5.590

3.  Repetitive transcranial magnetic stimulation (rTMS) augmentation of selective serotonin reuptake inhibitors (SSRIs) for SSRI-resistant obsessive-compulsive disorder (OCD): a meta-analysis of randomized controlled trials.

Authors:  Zhong-Rui Ma; Li-Jun Shi
Journal:  Int J Clin Exp Med       Date:  2014-12-15

Review 4.  Second generation antipsychotic-induced obsessive-compulsive symptoms in schizophrenia: a review of the experimental literature.

Authors:  Trehani M Fonseka; Margaret A Richter; Daniel J Müller
Journal:  Curr Psychiatry Rep       Date:  2014-11       Impact factor: 5.285

5.  A prospective study of paediatric obsessive-compulsive symptomatology in a Spanish community sample.

Authors:  Núria Voltas; Carmen Hernández-Martínez; Victoria Arija; Estefania Aparicio; Josefa Canals
Journal:  Child Psychiatry Hum Dev       Date:  2014-08

6.  The 5-HT7 receptor influences stereotypic behavior in a model of obsessive-compulsive disorder.

Authors:  Peter B Hedlund; J Gregor Sutcliffe
Journal:  Neurosci Lett       Date:  2007-01-11       Impact factor: 3.046

Review 7.  The 5-HT7 receptor and disorders of the nervous system: an overview.

Authors:  Peter B Hedlund
Journal:  Psychopharmacology (Berl)       Date:  2009-08-01       Impact factor: 4.530

8.  Buprenorphine augmentation in the treatment of refractory obsessive-compulsive disorder.

Authors:  Malcolm B Liddell; Victor Aziz; Patrick Briggs; Nimalee Kanakkehewa; Omar Rawi
Journal:  Ther Adv Psychopharmacol       Date:  2013-02

9.  The relationships between obsessive-compulsive symptom dimensions and cognitions in obsessive-compulsive disorder.

Authors:  Vlasios Brakoulias; Vladan Starcevic; David Berle; Denise Milicevic; Anthony Hannan; Andrew Martin
Journal:  Psychiatr Q       Date:  2014-06

10.  Use of antipsychotics and the risk of acute respiratory failure among adults: A disease risk score-matched nested case-control study.

Authors:  Meng-Ting Wang; Chen Wei Lin; Chen-Liang Tsai; Yun-Han Wang; Jyun-Heng Lai; Chin-Bin Yeh; Ya-Ling Huang; Yu-Juei Hsu
Journal:  Br J Clin Pharmacol       Date:  2020-05-30       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.